中山脱肛医院哪家好(中山市最好的脱肛医院) (今日更新中)

VISTA, Calif. (KGTV) - Several North County residents want their money back from a failed Tiny Home community.  Vista resident Greg Dutton said he and a handful of others simply want their ,000 investments back from Janet Ashforth, the brains behind Habitats Tiny Homes, which was planned for a plot of land between Escondido and Poway.“Sounded like a great idea,” said Dutton.  “A whole bunch of tiny homes.  Community garden.  Community clubhouse.”His excitement turned to frustration when he didn’t like the property Ashforth secured.“Really hard to get to.  Hardly any access roads,” he said.Dutton said Ashforth promised to refund his money if he didn’t like the property. However, Dutton requested the refund after Ashforth went into escrow for the property. He showed an email apparently from Ashforth saying he was too late to ask for the refund but she’d return the money anyway.Dutton still hasn’t received his refund. He and several other investors have filed claims at the Courthouse in Vista.10News spoke with Ashforth by phone. She said the project failed “when 30 people didn’t follow through and now they’re expecting their money back.”  She explained none of her investors ordered their tiny homes or took the next steps to keep the project alive.She argued, “The receipt clearly says you can get your deposit back until we open escrow on the property.”  Ashforth said Dutton requested after escrow opened.“I apologize,” she continued. “However, you should take responsibility for the receipt. I don’t have the money to give back because it was invested in the 0,000 property we’re now trying to sell.”Ashforth said she’ll gladly appear in court but admits the money is wrapped up in an empty plot of land. 1826

Warner University places the highest priority on the health and safety of its students and student athletes. Certified athletic trainers were on hand at the time that the athlete collapsed and provided immediate emergency care. The cause of Theo's collapse and ultimate death are not currently known, and it would be inappropriate to speculate regarding the cause of death at this time.On behalf of Warner University and our faculty, staff, coaches and trainers, we offer our deepest sympathies and heartfelt prayers to Theo's family, friends and teammates in this difficult and uncertain time. We are devastated by his passing. We have made a Warner University Care Team available to provide compassion, support and counseling to members of our community. We know that our students, coaches and staff are in the hearts, prayers and minds of this community, and we thank you for your continued love and support. 919

Walmart is making its opioid policy more strict, limiting the duration of such prescriptions and requiring that they be filled electronically.The company announced on Monday that within 60 days, it will only fill first-time acute opioid prescriptions for seven days or less nationwide, and it will limit the dosage to 50 morphine milligram equivalents, or MMEs, per day. The CDC publishes?MME conversion guides to help pharmacists figure out the right dosage for each type of prescribed opioid.There are more than 5,300 Walmart and Sam's Club locations in the United States.The new restrictions follow recommendations from the Centers for Disease Control and Prevention. A CDC study found that people who were prescribed at least one day of opioid therapy had a 6% chance of being addicted a year later — but for those prescribed eight or more days of treatment saw that chance spiked to 13.5%. The CDC also notes that patients who are prescribed higher dosages are more likely to die from an overdose.Some states already limit prescriptions to seven days or fewer. Walmart will go by state law when the cap is lower than one week.Walmart also said that starting in 2020, it will require e-prescriptions for controlled substances. The company explained that online prescriptions will help prevent prescription fraud and minimize error.The new measures are an extension of Walmart's efforts to fight the US opioid epidemic.In January, the company introduced a way to safely destroy leftover opioids at home. DisposeRx is a powder that, when combined with water and the pills, creates a gel that is difficult to remove from its container. The mixture can be thrown out at home or left at a drop off location. The company said on Monday that it will make DisposeRx available online.Plus, Walmart and Sam's Club pharmacists will continue to recommend the anti-overdose drug naloxone, which is available over the counter in some states, to customers who may be at risk of an overdose. They will complete a pain management curriculum by the end of August.Other companies are making similar efforts to help fight the epidemic.Aetna started waiving co-pays for the anti-overdose drug Narcan, a branded version of the naloxone nasal spray, and limiting first-time opioid prescriptions to seven days in January. And CVS Caremark, the prescription benefit manager for CVS Health, began capping first-time prescriptions at seven days in February.Purdue Pharma, which makes the opioid OxyContin, said in February that it will stop promoting the addictive painkiller to doctors.The CDC said in March that more than 63,000 Americans died of a drug overdose in 2016, and that nearly two-thirds of those overdoses involved either a prescription or illegal opioid, like heroin and fentanyl. 2830

Wall Street does not like the mixed messages coming out of the White House on trade.The Dow fell 600 points, or 2.4%, on Friday afternoon. The Nasdaq plunged 3%, while the S&P 500 retreated 2.4%.The Dow closed for the day down 588 points.Stocks had been trading higher earlier Friday, but the market turned sharply lower following conflicting messages coming out of the Trump administration about trade.While White House economic adviser Larry Kudlow sounded an optimistic note about China talks on CNBC, trade adviser Peter Navarro was simultaneously warning on CNN of higher tariffs if issues aren't resolved during the 90-day negotiating period."We've gotten a hodge-podge of mixed messages from people in the same administration," said Art Hogan, chief market strategist at B. Riley FBR. "We're not sure who we're supposed to listen to."Investors also received a softer jobs report on Friday. The Labor Department said the United States?added 155,000 jobs in November, missing expectations for a gain of 200,000. But the labor news did not trigger a selloff and some traders likely figured the slowdown in hiring will reduce pressure on the Federal Reserve to raise interest rates.Worries about the negative consequences of the trade war and hopes for progress have launched Wall Street on a wild ride of late. The US-China ceasefire sent stocks soaring on Monday. But doubts about the truce helped knock the Dow nearly 800 points into the red on Tuesday. And then the Dow plunged 785 points on Thursday before staging a huge comeback."It doesn't feel like much of a ceasefire," said Ed Yardeni, president of investment advisory Yardeni Research. 1697

WASHINGTON — U.S. health officials have started two new studies to test various blood thinners to try to prevent strokes, heart attacks, blood clots and other complications in COVID-19 patients.Doctors increasingly are finding blood clots throughout the bodies of many people who died from COVID-19 along with signs of damage they do to kidneys, lungs, blood vessels, the heart and other organs.National Heart, Lung and Blood Institute Director Gary Gibbons says that hospitals have been giving seriously ill patients anti-clotting drugs to try to prevent this, but “quite frankly, we didn’t know how best to treat it” in terms of which drugs or doses to use and at what stage of illness.The National Institutes of Health will coordinate a study in hospitalized patients comparing low and regular doses of the blood thinner heparin. The study will involve more than 100 sites around the world participating in a research effort with various governments, drug companies, universities and others to speed coronavirus therapies.A second study in COVID-19 patients not sick enough to need hospitalization will test various strategies against placebo pills: baby aspirin or low or regular doses of the anti-clotting drug apixaban, sold as Eliquis in the United States. The goal there is preventing blood clots or hospitalization.A third study starting later will test blood thinners for people who have recovered and no longer test positive for the coronavirus. Evidence is building that they may remain at higher risk for blood clots. 1538

来源：资阳报